The model entails use of personalized risk scores for melanoma prevention based on clinically validated algorithms, which are implemented into health system's melanoma screening model, covering full prevention and early detection pathway (continuum of care). Provision of the prevention suggestions will be provided with the help of GPs and behaviour change is initiated with clinically validated suggestions. Our approach builds on Estonian biobank cooperation and existing network of Dermtest’s GPs and other experts to pilot, validate, improve and scale this systematic and sustainable model of ‘solving melanoma’.
This activity has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union's Horizon 2020 research and innovation programme.
